Cardiometabolic Risk of Shiftwork
Launched by UNIVERSITY OF CHICAGO · Dec 20, 2010
Trial Information
Current as of May 09, 2025
Terminated
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Day workers and shift workers at the University of Chicago, University of Chicago Medical Center, or another Chicago area medical center who have maintained their work schedule (at least 30 hours/week) for at least 6 months.
- • Individuals who have been shift workers for less than 10 years; body mass index \<40 kg/m2;
- • No major illness
- • No history of psychiatric, endocrine, cardiac or sleep disorders
- • Those with hypertension or dyslipidemia will be included if these conditions are controlled by a stable treatment.
- • Women taking oral contraceptive or hormonal replacement therapy will be included only if they plan to stay on a stable regimen throughout the study.
- • Age must be between 18 and 50 years
- Exclusion Criteria:
- • Individuals who have worked at the University of Chicago, University of Chicago Medical Center, or another Chicago area medical center in their current position for less than 6 months.
- • Individuals who have been shift workers for more than 10 years
- • BMI\>40 kg/m2
- • Individuals with a major illness (e.g. diabetes, sleep disorder)
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Eve Van Cauter
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials